z-logo
Premium
Hop‐derived prenylflavonoids are substrates and inhibitors of the efflux transporter breast cancer resistance protein ( BCRP / ABCG 2)
Author(s) -
Tan Kee W.,
Cooney Janine,
Jensen Dwayne,
Li Yan,
Paxton James W.,
Birch Nigel P.,
Scheepens Arjan
Publication year - 2014
Publication title -
molecular nutrition and food research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.495
H-Index - 131
eISSN - 1613-4133
pISSN - 1613-4125
DOI - 10.1002/mnfr.201400288
Subject(s) - efflux , atp binding cassette transporter , chemistry , abcg2 , xanthohumol , pharmacology , biochemistry , transporter , biology , ecology , key (lock) , gene
Scope Hops ( Humulus lupulus L.) produce unique prenylflavonoids that exhibit interesting bioactivities. This study investigates the interactions between selected prenylflavonoids and breast cancer resistance protein ( BCRP / ABCG 2), an efflux transporter important for xenobiotic bioavailability and multidrug resistance ( MDR ). Methods and results ABCG 2‐inhibitory activity of xanthohumol ( XN ), isoxanthohumol ( IX ), 6‐prenylnaringenin (6‐ PN ), 8‐prenylnaringenin (8‐ PN ), and 6,8‐diprenylnarigenin (6,8‐diPN) was evaluated using mitoxantrone accumulation and vesicular transport assays. XN , IX , and 8‐ PN were tested for a substrate‐type relationship with ABCG 2 using ATP ase and bidirectional transport assays. The prenylflavonoids exhibited significant ABCG 2‐inhibitory activities in mitoxantrone accumulation and vesicular transport assays. In the ATP ase assay, XN , IX , and 8‐ PN inhibited baseline and sulfasalazine‐stimulated ATP ase activities with IC 50 of 2.16–27.0 μM. IX and 8‐ PN also displayed bell‐shaped activation curves in Ko143‐suppressed membranes, indicating a substrate‐type relationship. For IX, efflux ratios of 1.25 ± 0.21 and 9.18 ± 0.56 were observed in wild type and ABCG 2‐overexpressing MDCKII cell monolayers, respectively. The latter was reduced to 1.25 ± 0.15 in the presence of the ABCG 2‐specific inhibitor Ko143, demonstrating an ABCG 2‐mediated efflux of IX . Additionally, evidence was shown for the involvement of ABCG 2 in the efflux of 8‐ PN and/or its sulfate conjugate. Conclusion Prenylflavonoids are potent inhibitors of ABCG 2 and therefore implicated in ABCG 2‐mediated food/herb‐drug interactions and MDR . ABCG 2‐mediated efflux of prenylflavonoids may represent one mechanism that regulates prenylflavonoid bioavailability.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here